γ-tocotrienol attenuates TNF-α-induced changes in secretion and gene expression of MCP-1, IL-6 and adiponectin in 3T3-L1 adipocytes
暂无分享,去创建一个
K. Tsuda | T. Kondoh | Tetsuro Matsunaga | T. Adachi | Erina Joo | N. Gu | K. Yasuda | A. Shoji | Shiho Li | H. Yamazaki
[1] R. Sen,et al. Role of NF-κB in the Anti-Inflammatory Effects of Tocotrienols , 2010 .
[2] R. Sen,et al. Role of NF-kappaB in the anti-inflammatory effects of tocotrienols. , 2010, Journal of the American College of Nutrition.
[3] U. Garbin,et al. The effects of adiponectin on interleukin-6 and MCP-1 secretion in lipopolysaccharide-treated 3T3-L1 adipocytes: role of the NF-kappaB pathway. , 2009, International journal of molecular medicine.
[4] K. Chopra,et al. Attenuation of diabetic nephropathy by tocotrienol: involvement of NFkB signaling pathway. , 2009, Life sciences.
[5] Reiko Ohmori,et al. Tocotrienol suppresses adipocyte differentiation and Akt phosphorylation in 3T3-L1 preadipocytes. , 2009, The Journal of nutrition.
[6] Po-Len Liu,et al. Tocotrienol-rich fraction of palm oil exhibits anti-inflammatory property by suppressing the expression of inflammatory mediators in human monocytic cells. , 2008, Molecular nutrition & food research.
[7] W. Cawthorn,et al. TNF‐α and adipocyte biology , 2008 .
[8] W. Cawthorn,et al. TNF-alpha and adipocyte biology. , 2008, FEBS letters.
[9] C. Sen,et al. Tocotrienols in health and disease: the other half of the natural vitamin E family. , 2007, Molecular aspects of medicine.
[10] D. Das,et al. Tocotrienols in cardioprotection. , 2007, Vitamins and hormones.
[11] G. Hotamisligil,et al. Inflammation and metabolic disorders , 2006, Nature.
[12] B. Teferedegne,et al. Mechanism of Action of a Distal NF-κB-Dependent Enhancer , 2006, Molecular and Cellular Biology.
[13] Lars-Åke Appelqvist,et al. The chemistry and antioxidant properties of tocopherols and tocotrienols , 1996, Lipids.
[14] B. Teferedegne,et al. Mechanism of action of a distal NF-kappaB-dependent enhancer. , 2006, Molecular and cellular biology.
[15] J. K. Kim,et al. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-α in 3T3-L1 adipocytes , 2005 .
[16] J. K. Kim,et al. c-Jun N-terminal kinase is involved in the suppression of adiponectin expression by TNF-alpha in 3T3-L1 adipocytes. , 2005, Biochemical and biophysical research communications.
[17] A. Itai,et al. A novel IKKbeta inhibitor stimulates adiponectin levels and ameliorates obesity-linked insulin resistance. , 2004, Biochemical and biophysical research communications.
[18] S. Ima-Nirwana,et al. Effects of tocopherols and tocotrienols on body composition and bone calcium content in adrenalectomized rats replaced with dexamethasone. , 2004, Journal of medicinal food.
[19] A. Aljada,et al. Inflammation: the link between insulin resistance, obesity and diabetes. , 2004, Trends in immunology.
[20] Michael Karin,et al. The IKK NF-kappa B system: a treasure trove for drug development. , 2004, Nature reviews. Drug discovery.
[21] K. Yamashita,et al. Dietary Sesame Seeds Elevate α- and γ-Tocotrienol Concentrations in Skin and Adipose Tissue of Rats Fed the Tocotrienol-Rich Fraction Extracted from Palm Oil , 2001 .
[22] M. Matsuda,et al. PPARgamma ligands increase expression and plasma concentrations of adiponectin, an adipose-derived protein. , 2001, Diabetes.
[23] Y. Terauchi,et al. The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity , 2001, Nature Medicine.
[24] P. Anderson,et al. Inhibition of the transcription factors AP-1 and NF-kappaB in CD4 T cells by peroxisome proliferator-activated receptor gamma ligands. , 2001, International immunopharmacology.
[25] P. Tak,et al. NF-kappaB: a key role in inflammatory diseases. , 2001, The Journal of clinical investigation.
[26] K. Yamashita,et al. Dietary sesame seeds elevate alpha- and gamma-tocotrienol concentrations in skin and adipose tissue of rats fed the tocotrienol-rich fraction extracted from palm oil. , 2001, The Journal of nutrition.
[27] P. Tak,et al. NF-κB: a key role in inflammatory diseases , 2001 .
[28] B. Spiegelman,et al. Negative regulation of peroxisome proliferator-activated receptor-gamma gene expression contributes to the antiadipogenic effects of tumor necrosis factor-alpha. , 1996, Molecular endocrinology.
[29] B. Spiegelman,et al. Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance. , 1995, The Journal of clinical investigation.
[30] B. Spiegelman,et al. Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance. , 1993, Science.